This is one of the few studies that substantiate the implication of CYP1B1 and CYP1A1 to a lesser extent, in cancer therapy due to their differential enzyme activity overexpression in bladder, and colon tumors. This evidence concerns the gene CYP1A1 and colonic neoplasm.